Oncolytics Biotech (ONCY) Reports In-Line Q2 EPS
Oncolytics Biotech (NASDAQ: ONCY) reported Q2 EPS of ($0.10), in-line with the analyst estimate of ($0.10).
For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share